NCT01775137 - Ext. Long-term Safety Study in CF Patients: Single Arm TIP | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Long-term Safety of TIP

Interventions

DRUG

TBM100

Tobramycin inhalation powder (TIP) 112mg/b.i.d

Trial Locations (21)

1121

Novartis Investigative Site, Budapest

2305

Novartis Investigative Site, New Lambton Heights

3052

Novartis Investigative Site, Parkville

29425

Novartis Investigative Site, Charleston

37126

Novartis Investigative Site, Verona

44308

Novartis Investigative Site, Akron

45147

Novartis Investigative Site, Essen

46026

Novartis Investigative Site, Valencia

50139

Novartis Investigative Site, Florence

64020

Novartis Investigative Site, Monterrey

75230

Novartis Investigative Site, Dallas

77030

Novartis Investigative Site, Houston

90100

Novartis Investigative Site, Palermo

98125

Novartis Investigative Site, Messina

C1425DTG

Novartis Investigative Site, Caba

C1425EFD

Novartis Investigative Site, Capital Federal

X5014AKN

Novartis Investigative Site, Córdoba

H3T1C5

Novartis Investigative Site, Montreal

00161

Novartis Investigative Site, Roma

06720

Novartis Investigative Site, Mexico City

08035

Novartis Investigative Site, Barcelona